General semaglutide use Blood sugar can be affected by stress, illness, surgery, exercise, alcohol use, or skipping meals
Routine Monitoring Recommendations The American Diabetes Association recommends regular monitoring for patients on tirzepatide, including: hemoglobin A1c every 3 months initially, then every 6 months once stable
Combining the therapeutic approaches of GLP-1 agonists (which target extrahepatic mechanisms for metabolic disorders) with resmetirom (which target intrahepatic mechanisms for MASH and liver fibrosis) seems like a promising strategy for addressing fat accumulation, inflammation, and fibrosis associated with MASH
Lord, A
173,174 Collectively, these mechanisms of action make GLP-1 RAs an important therapeutic agent for the treatment of IR and for improving glycemic control
And it's saying here, OK, we know there's a problem here